HIGHLIGHTS
- who: Elena Mata and collaborators from the NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain have published the Article: Malaria Vaccine Adjuvants: Latest Update and Challenges in Preclinical and Clinical Research, in the Journal: (JOURNAL) of 14/01/2013
- what: Another handicap for malaria vaccine development derives from the traditional strategies of research focused on the antigen-targeting approach, not considering the role of other components of the formulation that can induce and modulate the immune_response.
SUMMARY
It produces strong antibody . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.